Biostax Corp.
BTAX
$0.0002
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 911.00K | 1.04M | 1.00M | 957.50K | 944.20K |
| Depreciation & Amortization | 13.80K | 27.20K | 40.60K | 54.00K | 40.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 970.90K | 1.21M | 1.35M | 1.48M | 1.46M |
| Operating Income | -970.90K | -1.21M | -1.35M | -1.48M | -1.46M |
| Income Before Tax | -1.85M | -2.21M | -2.28M | -2.36M | -1.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.85 | -2.21 | -2.28 | -2.36 | -1.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.85M | -2.21M | -2.28M | -2.36M | -1.59M |
| EBIT | -970.90K | -1.21M | -1.35M | -1.48M | -1.46M |
| EBITDA | -916.70K | -1.16M | -1.29M | -1.43M | -1.15M |
| EPS Basic | -0.02 | -0.03 | -0.03 | -0.03 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.03 | -0.03 | -0.03 | -0.03 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 334.83M | 334.30M | 333.89M | 333.42M | 333.00M |
| Average Diluted Shares Outstanding | 336.91M | 336.37M | 335.96M | 333.42M | 333.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |